A 3-week gemcitabine-cisplatin regimen for metastatic urothelial cancer.


OBJECTIVE To assess the efficacy and tolerability of a 3-week outpatient schedule of intravenous gemcitabine and cisplatin in patients with locally advanced unresectable or metastatic transitional cell carcinoma of the urothelial tract (TCC). PATIENTS AND METHODS A two-stage phase II trial enrolled TCC patients with Karnofsky performance status > or = 60… (More)